159 related articles for article (PubMed ID: 34575504)
1. siRNA-Loaded Hydroxyapatite Nanoparticles for
Luo D; Xu X; Iqbal MZ; Zhao Q; Zhao R; Farheen J; Zhang Q; Zhang P; Kong X
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575504
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer.
Huang R; Du H; Cheng L; Zhang P; Meng F; Zhong Z
Acta Biomater; 2023 Sep; 168():529-539. PubMed ID: 37451658
[TBL] [Abstract][Full Text] [Related]
3. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
5. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
6. Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.
Pei Y; Chen L; Huang Y; Wang J; Feng J; Xu M; Chen Y; Song Q; Jiang G; Gu X; Zhang Q; Gao X; Chen J
Small; 2019 Jun; 15(24):e1900631. PubMed ID: 31033217
[TBL] [Abstract][Full Text] [Related]
7. Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy.
Xia Y; Zhao M; Chen Y; Hua L; Xu T; Wang C; Li Y; Zhu B
RSC Adv; 2018 Jul; 8(46):25932-25940. PubMed ID: 35541982
[TBL] [Abstract][Full Text] [Related]
8. Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles.
Mehta A; Dalle Vedove E; Isert L; Merkel OM
Pharm Res; 2019 Jul; 36(9):133. PubMed ID: 31289919
[TBL] [Abstract][Full Text] [Related]
9. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
[TBL] [Abstract][Full Text] [Related]
10. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
11. Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy.
Xu Y; Yu Z; Fu H; Guo Y; Hu P; Shi J
ACS Appl Mater Interfaces; 2022 May; 14(19):21836-21847. PubMed ID: 35512029
[TBL] [Abstract][Full Text] [Related]
12. Bioreducible, arginine-rich polydisulfide-based siRNA nanocomplexes with excellent tumor penetration for efficient gene silencing.
Zhang X; Hong K; Sun Q; Zhu Y; Du J
Biomater Sci; 2021 Jul; 9(15):5275-5292. PubMed ID: 34180478
[TBL] [Abstract][Full Text] [Related]
13. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing.
Pinese C; Lin J; Milbreta U; Li M; Wang Y; Leong KW; Chew SY
Acta Biomater; 2018 Aug; 76():164-177. PubMed ID: 29890267
[TBL] [Abstract][Full Text] [Related]
14. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
15. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery.
Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Suppression of Tumor Angiogenesis by the Co-delivering of Vascular Endothelial Growth Factor Targeted siRNA and Candesartan Mediated by Functionalized Carbon Nanovectors.
Ding X; Su Y; Wang C; Zhang F; Chen K; Wang Y; Li M; Wang W
ACS Appl Mater Interfaces; 2017 Jul; 9(28):23353-23369. PubMed ID: 28617574
[TBL] [Abstract][Full Text] [Related]
17. Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors.
Anthiya S; Öztürk SC; Yanik H; Tavukcuoglu E; Şahin A; Datta D; Charisse K; Álvarez DM; Loza MI; Calvo A; Sulheim E; Loevenich S; Klinkenberg G; Schmid R; Manoharan M; Esendağlı G; Alonso MJ
J Control Release; 2023 May; 357():67-83. PubMed ID: 36921725
[TBL] [Abstract][Full Text] [Related]
18. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
19. Milk exosomes - Natural nanoparticles for siRNA delivery.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
[TBL] [Abstract][Full Text] [Related]
20. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
